JANUARY 2025 ISSUE
Applied Policy Insight begins 2025 with a policy primer for the coming months. We discuss the budget reconciliation process, which Republicans will use to advance President-elect Trump’s economic agenda in Congress. We also consider the return of Schedule F and…
December 2024
How our commitment to saving lives has driven a record of success for clients, an analysis of the Part B drugs subject to inflation rebates for 2024, and a look at our 2024 stories with an eye toward changes under…
November 2024
Possible changes in health policy under a new presidential administration in 2025; the implications of a forthcoming rule from HHS, the Departments of Labor and Treasury on copay accumulators and maximizers; and the future of CMS’s Best Price ‘Stacking’ proposal.
October 2024
The possibility of MAC consolidations, a summary of CMS’s education session on the Transitional Coverage for Emerging Technologies (TCET) pathway and the latest on another delay of PAMA implementation.
September 2024
An examination of compounding pharmacies and the anniversary of the two-midnight rule.
August 2024
The response of non-diabetes advocacy groups to MEDCAC’s consideration of diabetes devices, a look at states’ responses to healthcare issues, and a primer on patent thickets.
July 2024
The impact of recent Supreme Court decisions on healthcare policy and the launch of the Applied Policy podcast.
June 2024
The transformation of Medicare Part D with an examination of the new out-of-pocket cap and Medicare prescription payment and the challenges of realizing heat equity in extreme heat.
May 2024
The FDA’s final rule on LDTs, the TEAM model and value-based care, an opportunity to advise CMS on addressing prior authorization issues in the Medicare Advantage Program.
April 2024
Medicare and Medicaid Disproportionate Share Hospital programs, our visit to MedTrade, and the inaugural edition of our new column on artificial intelligence.
March 2024
A primer on CMS’s competitive bidding and the history of the Scribner shunt.
